Coronavirus
Japan's Shionogi seeks approval for COVID pill in South Korea
Drugmaker pursues first overseas authorization for Xocova treatment
Drugmaker pursues first overseas authorization for Xocova treatment
Requirement also applies to visitors from Hong Kong and Macau
Measures include ban on ads for products with highest levels of sugar
Cross-regional support seen unacceptable to already-stretched local frontline professionals
Official count remains low, but country likely seeing 5,000 deaths a day
New system means tech can be in commercial use within a year of development
Saathi's plant-based, plastic-free napkins go easy on environment and women
Studies indicate that less schooling likely increases risk
Investment firm specializes in health care, education and lifestyle sectors
Chinese smartphone maker diversifying product portfolio to fight soft demand
Market leader sees stock price plunge 90% from peak as chairman predicts more losses
Japan drugmaker zeros in on potential 'wonder pill' for psoriasis, other conditions
Cases found via checkups remain 1.2% below pre-pandemic level
Health tech app operator aims to attract 100 million users for home market
Auto parts supplier's MGC Diagnostics deal part of push to branch out
Swiss entrepreneurs turn COVID setbacks into growth engine
Studies show Asia-Pacific region has lower antibody rate than Europe, U.S.
Investcorp leads Series D round for owner of Clove Dental chain
Jakarta now has homegrown halal alternative to Western, Chinese shots
Company operates as a virtual clinic and hospital care provider
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.